drugset
drugset / Trial / NCT04185805

Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers (III)

NCT04185805 ↗

Phase 1 Unknown 24 enrolled Daewoong Pharmaceutical Co. LTD.
RandomizedCrossoverOpen-labelBasic science

Summary

This is a randomized, open-label, single dose study to evaluate the safety and pharmacokinetics of DWP14012 tablet A and DWP14012 tablet B in healthy volunteers

Timeline

Start
2019-12-14
Primary completion
2020-02-28
Completion
2020-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject ABEPRAZAN Small molecule — —

Indications

No indication recorded.